ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.05
0.49%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,308.905
-0.26%
Brent Oil
83.56
0.84%
Bitcoin
61,168.94
-1.85%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Avanir Pharmaceuticl (AVN.R)

  7. Avanir Pharmaceuticl (AVN.R) News

Avanir (AVN.R)

Avanir Pharmaceuticl
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AVN.R
DateTimeSourceHeadlineSymbolCompany
11/04/200613:00Business WireAVANIR Stock to Commence Trading on the NASDAQ National Market SystemAMEX:AVN.RAvanir Pharmaceuticl
04/04/200613:00Business WireAVANIR's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression DisorderAMEX:AVN.RAvanir Pharmaceuticl
03/04/200621:15Business WireAVANIR to Change Listing to the NASDAQ National Market System; Trading will Commence on April 11, Under the Ticker Symbol AVNRAMEX:AVN.RAvanir Pharmaceuticl
29/03/200622:15Business WireAVANIR Pharmaceuticals Invites Investors to Listen to the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals CAMEX:AVN.RAvanir Pharmaceuticl
01/03/200621:15Business WireAVANIR Pharmaceuticals Hires Matthew R. Ruth as Vice President of SalesAMEX:AVN.RAvanir Pharmaceuticl
09/02/200621:05Business WireAVANIR Pharmaceuticals Reports First Quarter of Fiscal Year 2006 ResultsAMEX:AVN.RAvanir Pharmaceuticl
06/02/200621:15Business WireAVANIR Receives Approximately $4.2 Million from Exercise of WarrantsAMEX:AVN.RAvanir Pharmaceuticl
06/02/200617:15Business WireAVANIR Pharmaceuticals Holds Annual Meeting of ShareholdersAMEX:AVN.RAvanir Pharmaceuticl
30/01/200611:00Business WireAVANIR Submits Expanded Neurodex New Drug Application for the Treatment of Involuntary Emotional Expression DisorderAMEX:AVN.RAvanir Pharmaceuticl
18/01/200616:25Business WireCORRECTING and REPLACING AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on Thursday, February 9,AMEX:AVN.RAvanir Pharmaceuticl
18/01/200613:30Business WireAVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on February 9, 2006AMEX:AVN.RAvanir Pharmaceuticl
 Showing the most relevant articles for your search:AMEX:AVN.R

Your Recent History

LSE
BOO
Boohoo
LSE
POS
Plexus
LSE
CHLL
Chill Brands
LSE
AAZ
Anglo Asian Mining
LSE
RR.
Rolls-royce
LSE
VAST
Vast Resources
LSE
CSFS
Cornerstone Fs
LSE
AGL
Angle
LSE
PET
Petrel Resources
LSE
ALGW
Alpha Growth
LSE
GCM
Gcm Resources
LSE
BARC
Barclays
LSE
KEFI
Kefi Gold And Copper
LSE
SYME
Supply@me Capital
LSE
APH
Alliance Pharma
LSE
TERN
Tern
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved